Using carefully constructed case vignettes and a survey of oncology providers across a spectrum of settings, we sought to characterize early trends in internalization of the girentuximab PET-CT into care.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina
Gianpaolo Carpinito
Urology
Clinical or Medical
Observational
Cancer (Kidney)
UNC or UNC Health employees
24-2566
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
